Guardant Health to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Guardant Health (Nasdaq: GH) announces its participation in two upcoming virtual investor conferences. The 10th Annual SVB Leerink Global Healthcare Conference will feature a fireside chat on February 26 at 1:20 p.m. PT. Additionally, the Cowen 41st Annual Health Care Conference will hold a fireside chat on March 2 at 8:10 a.m. PT. Interested parties can access live and archived webcasts on the company’s website. Guardant Health is a leader in precision oncology, focusing on blood tests and advanced analytics to improve cancer patient outcomes and lower healthcare costs.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following virtual investor conferences.

• 10^th Annual SVB Leerink Global Healthcare Conference
  Fireside Chat on Friday, February 26^th at 1:20 p.m. Pacific Time / 4:20 p.m. Eastern Time
• Cowen 41^st Annual Health Care Conference
  Fireside Chat on Tuesday, March 2^nd at 8:10 a.m. Pacific Time / 11:10 a.m. Eastern Time

Interested parties may access a live and archived webcast of the virtual sessions on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched liquid biopsy-based Guardant360^®, Guardant360 CDx, and GuardantOMNI^® tests for advanced stage cancer patients, and Guardant Reveal^™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.

Source: Guardant Health, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210217005765/en/

FAQ

What date is Guardant Health participating in the SVB Leerink Global Healthcare Conference?

Guardant Health will participate in the SVB Leerink Global Healthcare Conference on February 26 at 1:20 p.m. PT.

When is the Cowen 41st Annual Health Care Conference for Guardant Health?

The Cowen 41st Annual Health Care Conference for Guardant Health is scheduled for March 2 at 8:10 a.m. PT.

How can I access the webcasts of Guardant Health's investor conferences?

You can access the live and archived webcasts of Guardant Health's investor conferences on their website under the 'Investors' section.

What type of company is Guardant Health?

Guardant Health is a leading precision oncology company specializing in blood tests and analytics to improve cancer treatment and outcomes.

What products does Guardant Health offer for cancer detection?

Guardant Health offers products including Guardant360, Guardant360 CDx, GuardantOMNI, and Guardant Reveal for various stages of cancer detection.